• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

AU1

CAS No. 1802251-00-8

AU1 ( GSK 1379725A )

产品货号. M12752 CAS No. 1802251-00-8

AU1 (GSK 1379725A) is the first selective small molecule inhibitor of BPTF bromodomain (bromodomain PHD finger transcription factor) with Kd of 2.8 uM in a cell-based reporter assay.

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
5MG ¥1596 有现货
10MG ¥2811 有现货
25MG ¥4771 有现货
50MG ¥6820 有现货
100MG ¥9396 有现货
500MG ¥18873 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    AU1
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    AU1 (GSK 1379725A) is the first selective small molecule inhibitor of BPTF bromodomain (bromodomain PHD finger transcription factor) with Kd of 2.8 uM in a cell-based reporter assay.
  • 产品描述
    AU1 (GSK 1379725A) is the first selective small molecule inhibitor of BPTF bromodomain (bromodomain PHD finger transcription factor) with Kd of 2.8 uM in a cell-based reporter assay, shows no binding activity for Brd4; interferes with its regulatory activity in cultured cells.
  • 同义词
    GSK 1379725A
  • 通路
    Chromatin/Epigenetic
  • 靶点
    Bromodomain
  • 受体
    Bromodomain
  • 研究领域
    Other Indications
  • 适应症
    ——

化学信息

  • CAS Number
    1802251-00-8
  • 分子量
    450.47
  • 分子式
    C23H23FN6O3
  • 纯度
    >98% (HPLC)
  • 溶解度
    ——
  • SMILES
    O=C(OC)C1=CC=CC(NC(NC2CN(C3=NC(NC4=CC=C(F)C=C4)=NC=C3)CC2)=O)=C1
  • 化学全称
    Benzoic acid, 3-[[[[1-[2-[(4-fluorophenyl)amino]-4-pyrimidinyl]-3-pyrrolidinyl]amino]carbonyl]amino]-, methyl ester

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1. Urick AK, et al. ACS Chem Biol. 2015 Oct 16;10(10):2246-56.
产品手册
关联产品
  • ZL0454

    ZL0454 is a potent, highly selective small-molecule BRD4 inhibitor with IC50 of 49 and 32 nM for BRD4-BD1 and BRD4-BD2, respectively.

  • GSK-6853

    A potent, highly selective and cell-active BRPF1 bromodomain inhibitor with TR-FRET pIC50 of 8.1.

  • SJ830599

    SJ830599 is a modest selective BRD2-BD2 inhibitor with IC50 of 0.61 uM, 3.3-fold selectivity over BRD2-BD1.